US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27
AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and founder and managing director Hartley Atkinson believes it’s only going to get better as the growing Oz-based multinational pharmaceutical compan...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| MHJ | Ann: Investor Day Presentation April 2026 | 14/04/26 | 0 | 26 | |||
|
|||||||
| MHJ | Ann: Form 603 - Accident Compensation Corporation (ACC) | 13/04/26 | 0 | 10 | |||
|
|||||||
| MHJ | Ann: Notice of cessation of securities | 26/03/26 | 0 | 41 | |||
|
|||||||
| MHJ | Ann: Resignation/Appointment of Company Secretary | 18/03/26 | 0 | 15 | |||
|
|||||||
| MHJ | Ann: Half Year Accounts | 02/03/26 | 0 | 50 | |||
|
|||||||
| MHJ | Ann: FY26H1 Results | 02/03/26 | 0 | 39 | |||
|
|||||||
| MHJ | Ann: FY26H1 Results Presentation | 02/03/26 | 0 | 59 | |||
|
|||||||
| MHJ | Ann: Notification of cessation of securities | 16/02/26 | 0 | 29 | |||
|
|||||||
See All Discussions
NZX News